Literature DB >> 7744198

Carbon dioxide responsiveness in COPD patients with and without chronic hypercapnia.

G Scano1, A Spinelli, R Duranti, M Gorini, F Gigliotti, P Goti, J Milic-Emili.   

Abstract

To ascertain whether and to what extent the reduced ventilatory response to a hypercapnic stimulus in chronic obstructive pulmonary disease (COPD) patients depends on a blunted chemoresponsiveness of central origin or to mechanical impairment, we studied two groups of COPD patients without (group A) and with (group B) chronic hypercapnia, but with similar degrees of airway obstruction and hyperinflation. The study was performed on 17 patients (9 normocapnic and 8 hypercapnic). Six age-matched normal subjects (group C) were also studied as a control. During a CO2 rebreathing test, ventilation (VE), mouth occlusion pressure (P0.1), and the electromyographic activity of diaphragm (Edi) were recorded and then plotted against end-tidal carbon dioxide tension (PCO2). Inspiratory muscle strength was significantly lower in the hypercapnic group (group B) compared to normocapnic group (A), and in these groups compared to the control group (C). Both patient groups exhibited significantly lower delta VE/delta PCO2 than the control group. In hypercapnics, delta P0.1/delta PCO2 was significantly lower than in normocapnics and control group, whilst mouth occlusion pressure as % of maximal inspiratory pressure delta P0.1 (% MIP)/delta PCO2 did not differ significantly among the three groups. delta Edi/delta PCO2 increased from C to A. At a PCO2 of 8.65 kPa, VE was similar in the normocapnic and control group, but lower in hypercapnics; Edi was similar in hypercapnic and control group; but greater in normocapnics. P0.1(% MIP) did not differ significantly among groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744198     DOI: 10.1183/09031936.95.08010078

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

Review 1.  Providing perioperative care for patients with hip fractures.

Authors:  G T C Wong; N C H Sun
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

Review 2.  Assessing respiratory drive and central motor pathway in humans: clinical implications.

Authors:  B Binazzi; B Lanini; G Scano
Journal:  Lung       Date:  2004       Impact factor: 2.584

3.  Maximal Voluntary Breath-Holding Tele-Inspiratory Test in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Abir Hedhli; Azza Slim; Yassine Ouahchi; Meriem Mjid; Jamel Koumenji; Sana Cheikh Rouhou; Sonia Toujani; Besma Dhahri
Journal:  Am J Mens Health       Date:  2021 May-Jun

4.  CO2 rebreathing model in COPD: blood-to-gas equilibration.

Authors:  Jack A Loeppky; Milton V Icenogle; Arvind Caprihan; Marcos F Vidal Melo; Stephen A Altobelli
Journal:  Eur J Appl Physiol       Date:  2006-09-08       Impact factor: 3.346

5.  Increased ventilatory response to carbon dioxide in COPD patients following vitamin C administration.

Authors:  Sara E Hartmann; Christine K Kissel; Lian Szabo; Brandie L Walker; Richard Leigh; Todd J Anderson; Marc J Poulin
Journal:  ERJ Open Res       Date:  2015-09-15

6.  Pathogenesis of obstructive sleep apnea in individuals with the COPD + OSA Overlap syndrome versus OSA alone.

Authors:  Jeremy E Orr; Christopher N Schmickl; Bradley A Edwards; Pamela N DeYoung; Rebbecca Brena; Xiaoying S Sun; Sonia Jain; Atul Malhotra; Robert L Owens
Journal:  Physiol Rep       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.